Capgemini holds 11.43% of Altran’s share capital
Paris, July 2, 2019 – Capgemini (Euronext Paris: CAP) reports that it holds 29,378,319 Altran shares (Altran Technologies – Euronext Paris: ALT) as of today following the settlement and delivery of the off-market acquisition of a block of shares from a group of shareholders led by Apax Partners. This transaction is the result of the definite agreement to acquire this block, representing 11.43% of Altran’s share capital, signed on 24 June 2019.
In accordance with applicable regulations, these shares will be counted towards the acceptance threshold of the takeover bid on all Altran shares that Capgemini is contemplating and which would be set at 50.10% of the share capital and voting rights (on a fully diluted basis).
This press release is disseminated for information purposes only and does not constitute an offer to purchase, or a solicitation of an offer to sell, any securities of Altran Technologies.
The documentation relating to the tender offer which, if filed, will state the terms and conditions of the tender offer, will be submitted to the review of the Autorité des marchés financiers. Investors and shareholders are strongly advised to read the documentation relating to the tender offer when it becomes available, if the offer is filed, as well as any amendments and supplements to those documents as they will contain important information about Capgemini, Altran Technologies and the proposed transaction.
The transaction is notably subject to execution of definitive documentation and obtaining of required regulatory authorizations and other customary conditions. The tender offer would only be filed with the Autorité des marchés financiers after such conditions have been fulfilled.
This press release must not be published, broadcast or distributed, directly or indirectly, in any country in which the distribution of this information is subject to legal restrictions. The tender offer will not be open to the public in jurisdictions in which its launch is subject to legal restrictions. The publication, broadcasting or distribution of this press release in certain countries may be subject to legal or regulatory restrictions. Therefore, persons located in countries where this press release is published, broadcasted or distributed must inform themselves about and comply with such restrictions. Capgemini disclaims any responsibility for any violation of such restrictions.
 Altrafin Participations, M. Alexis Kniazeff and M. Hubert Martigny